Panbela Therapeutics at Risk: Penny Stock Classification May Weaken Legal Safeguards and Hurt Valuation
PremiumCompany AnnouncementsPanbela Therapeutics at Risk: Penny Stock Classification May Weaken Legal Safeguards and Hurt Valuation
6M ago
Panbela Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
Panbela Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
6M ago
PBLA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
PBLA Earnings Report this Week: Is It a Buy, Ahead of Earnings?
6M ago
Panbela Therapeutics Shifts from Nasdaq to OTCQB Market
PremiumCompany AnnouncementsPanbela Therapeutics Shifts from Nasdaq to OTCQB Market
7M ago
Panbela Therapeutics price target lowered to $5 from $16 at H.C. Wainwright
Premium
The Fly
Panbela Therapeutics price target lowered to $5 from $16 at H.C. Wainwright
7M ago
Panbela Therapeutics files to sell 255.6K shares of common stock for holders
Premium
The Fly
Panbela Therapeutics files to sell 255.6K shares of common stock for holders
8M ago
Panbela Therapeutics Issues New Shares Post-Warrant Exercise
PremiumCompany AnnouncementsPanbela Therapeutics Issues New Shares Post-Warrant Exercise
9M ago
Panbela Therapeutics Completes Common Stock Offering
Premium
Company Announcements
Panbela Therapeutics Completes Common Stock Offering
9M ago
Panbela Therapeutics Announces Public Offering Pricing
Premium
Company Announcements
Panbela Therapeutics Announces Public Offering Pricing
10M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100